• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【药物名称】Saxagliptin, BMS 477118, Onglyza

【化学名称】(1S,3S,5S)-2-[2(S)-Amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile

【CA登记号】361442-04-8, 945667-22-1 (monohydrate)

【 分 子 式 】C18H25N3O2

【 分 子 量 】315.4101

【开发单位】Bristol-Myers Squibb (US); licensed to AstraZeneca (GB).

【药理作用】Dipeptidyl Peptidase IV Inhibitor, Antidiabetic Agent

合成路线1

After protection of (S)-adamantylglycine (I) as the tert-butyl carbamate (II) with Boc2O and K2CO3, hydroxylation of the adamantane ring using KMnO4 in hot aqueous KOH gives the alcohol (III) (1). Alternatively, the Boc-protected amino acid (III) can be prepared by treatment of (3-hydroxyadamantyl)glycine (IV) with Boc2O and NaOH. Subsequent coupling of N-Boc-(S)-(3-hydroxyadamantyl)glycine (III) with (1S,3S,5S)-2-azabicyclo[3.1.0]hexane-3-carboxamide (V) using either EDC/HOBt or methanesulfonyl chloride and Hunig’s base produces amide (VI) (1-6). After protection of the hydroxyl group of (VI) with triethylsilyl triflate, the silylated carboxamide (VII) is dehydrated to the corresponding nitrile (VIII) by treatment with POCl3 and imidazole in pyridine. Deprotection of (VIII) employing trifluoroacetic acid in CH2Cl2 then gives saxagliptin (1). Scheme 1.
Alternatively, direct dehydration of unsilylated carboxamide (VI) with trifluoroacetic anhydride in the presence of pyridine or NaOH produces nitrile (IX), which undergoes acidic Boc group cleavage to furnish saxagliptin (2-6). Scheme 1.
In a related strategy, (3-hydroxyadamantyl)glycine (IV) is protected with either ethyl trifluoroacetate and potassium methoxide or dodecyl trifluorothioacetate and NaOH to give the trifluoroacetamide (X), which is further esterified with trifluoroacetic anhydride in isopropyl acetate to yield the N,O-bis(trifluoroacetyl) derivative (XI). After conversion of (XI) to the corresponding acid chloride (XII) by means of Vilsmeier reagent, condensation with the bicyclic carbonitrile (XIII) leads to amide (XIV). Hydrolysis of the trifluoroacetate ester (XIV) with NaHCO3 in MeOH provides (XV), from which the N-trifluoroacetyl group is reductively removed by means of NaBH4 to yield saxagliptin. Alternatively, the title compound is directly produced by treatment of the bis(trifluoroacetyl)-protected precursor (XIV) with NaBH4 in EtOH (7). Scheme 1.

1 Robl, J.A., Sulsky, R.B., Betebenner, D.A., Magnin, D.R., Hamann, L.G., Augeri, D.J. (Bristol-Myers Squibb Co.). Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method. EP 1261586, JP 2003531118, US 6395767, WO 0168603.
2 u, T.C., Hamann, L.G., Fox, R. et al. (Bristol-Myers Squibb Co.). Methods and compounds producing dipeptidyl peptidase IV inhibitors and intermediates thereof. JP 200651621, US 2005090539, WO 2004052850.
3 Politino, M., Cadin, M.M., Skonezny, P.M., Chen, J.G. (Bristol-Myers Squibb Co.). EP 1737970, JP 2007532137, WO 2005106011.
4 Sharma, P.N., Galvin, G.M., Boettger, S.D., Racha, S., Zhu, J., Melton, J., Mudryk, B. (Bristol-Myers Squibb Co.). Ammonolysis process for the preparation of intermediates for DPP IV inhibitors. US 2006035954, WO 2006020664.
5 Sharma, P.N. (Bristol-Myers Squibb Co.). Process for producing a dipeptidyl peptidase IV inhibitor. EP 1751102, US 2005267191, US 7214702, WO 2005115982.
6 Augeri, D.J., Robl, J.A., Betebenner, D.A. et al. Discovery and preclinical profile of saxagliptin (BMS-477118): A highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. J Med Chem 2005, 48(15): 5025-37.
7 Sharma, P.N., Gublo, E.J., Galvin, G.M., Boettger, S.D., Racha, S. (Bristol-Myers Squibb Co.). Process for preparing a dipeptidyl peptidase IV inhibitor and intermediates employed therein. WO 2005094323.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 65678 (S)-adamantylglycine 60256-21-5 C12H19NO2 详情 详情
(II) 65679 N-Boc-(S)-adamantylglycine   C17H28NO4 详情 详情
(III) 65680 N-Boc-(S)-(3-hydroxyadamantyl)glycine   C17H28NO5 详情 详情
(IV) 65681 (S)-(3-hydroxyadamantyl)glycine   C12H19NO3 详情 详情
(V) 65682 (1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide 361440-68-8 C6H10N2O 详情 详情
(VI) 65683     C23H36N3O5 详情 详情
(VII) 65684     C29H50N3O5Si 详情 详情
(VIII) 65685     C29H48N3O4Si 详情 详情
(IX) 65686     C22H34N3O5 详情 详情
(X) 65687     C14H18F3NO4 详情 详情
(XI) 65688     C16H17F6NO5 详情 详情
(XII) 65689     C16H16ClF6NO4 详情 详情
(XIII) 65690 (1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carbonitrile 866083-42-3 C6H8N2 详情 详情
(XIV) 65691     C22H23F6N3O4 详情 详情
(XV) 65692     C20H24F3N3O3 详情 详情

合成路线2

The intermediate (S)-adamantylglycine (I) can be prepared as follows. Reduction of adamantane-1-carboxylic acid (XVI) using LiAlH4 in THF gives the primary alcohol (XVII), which is oxidized to aldehyde (XVIII) under Swern conditions. Adamantane-1-carbaldehyde (XVIII) is then condensed with (R)-phenylglycinol (XIX) and KCN in the presence of NaHSO3 to yield the chiral aminonitrile (XX). After acidic hydrolysis of nitrile (XX) to the corresponding amino acid (XXI), the chiral auxiliary group is removed by hydrogenolysis over Pearlman’s catalyst to furnish intermediate (I) (1, 6). Scheme 2.

1 Robl, J.A., Sulsky, R.B., Betebenner, D.A., Magnin, D.R., Hamann, L.G., Augeri, D.J. (Bristol-Myers Squibb Co.). Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method. EP 1261586, JP 2003531118, US 6395767, WO 0168603.
6 Augeri, D.J., Robl, J.A., Betebenner, D.A. et al. Discovery and preclinical profile of saxagliptin (BMS-477118): A highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. J Med Chem 2005, 48(15): 5025-37.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 65644     C35H41INOPSSi 详情 详情
(XVI) 65693 1-Adamantanecarboxylic acid; Adamantane-1-carboxylic acid; Tricyclo[3.3.1.1(3,7)]decan-1-Carboxylic acid 828-51-3 C11H16O2 详情 详情
(XVII) 65694 1-Adamantanemethanol; 1-(Hydroxymethyl)adamantane; 1-Tricyclo[3.3.1.1(3,7)]decanemethanol 770-71-8 C11H18O 详情 详情
(XVIII) 65695 1-Adamantylcarboxaldehyde; Tricyclo[3.3.1.1(3,7)]decane-1-carboxaldehyde; 1-Formyladamantane 2094-74-8 C11H16O 详情 详情
(XIX) 14376 (2R)-2-amino-2-phenyl-1-ethanol; (R)-(-)-2-phenylglycinol; (R)-2-amino-2-phenyl-1-ethanol 56613-80-0 C8H11NO 详情 详情
(XX) 65696 (alphaS)-alpha-[[(1R)-2-Hydroxy-1-phenylethyl]amino]-tricyclo[3.3.1.1(3,7)]decane-1-acetonitrile 361441-95-4 C20H26N2O 详情 详情
(XXI) 65697     C20H27NO3 详情 详情

合成路线3

The preparation of the hydroxylated adamantane (IV) is shown in Scheme 3. 1-Adamantyl bromide (XXII) is condensed with 1,1,2-tris(trimethylsilyloxy)ethylene (XXIII) by means of ZnCl2 in CH2Cl2 to afford the adamantylglycolic acid (XXIV), which is esterified to (XXV) utilizing a solution of acetyl chloride in MeOH. After Swern oxidation of (XXV) to the corresponding keto ester (XXVI), hydroxylation of the adamantane ring by means of HNO3/H2SO4 provides (XXVII). Alkaline hydrolysis of ester (XXVII) leads to the oxoacetic acid (XXVIII), which is converted to the target (S)-amino acid (IV) by reductive amination with phenylalanine dehydrogenase (3).

3 Politino, M., Cadin, M.M., Skonezny, P.M., Chen, J.G. (Bristol-Myers Squibb Co.). EP 1737970, JP 2007532137, WO 2005106011.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IV) 65681 (S)-(3-hydroxyadamantyl)glycine   C12H19NO3 详情 详情
(XXII) 65698 1-Bromoadamantane; 1-Bromotricyclo[3.3.1.1(3,7)]decane; 1-Adamantyl bromide 768-90-1 C10H15Br 详情 详情
(XXIII) 14534 2,2,7,7-tetramethyl-4-[(trimethylsilyl)oxy]-3,6-dioxa-2,7-disila-4-octene; 1,2-bis[(trimethylsilyl)oxy]vinyl trimethylsilyl ether; TRIS(TRIMETHYLSILYLOXY)ETHYLENE 69097-20-7 C11H28O3Si3 详情 详情
(XXIV) 65699     C12H18O3 详情 详情
(XXV) 65700     C13H20O3 详情 详情
(XXVI) 65701     C13H18O3 详情 详情
(XXVII) 65702 Methyl 2-(3-Hydroxy-1-adamantyl)-2-oxoacetate   C13H18O4 详情 详情
(XXVIII) 65703 2-(3-Hydroxy-1-adamantyl)-2-oxoacetic acid; 3-Hydroxy-alpha-oxotricyclo[3.3.1.1(3,7)]decane-1-acetic acid; 709031-28-7 C12H16O4 详情 详情

合成路线4

The bicyclic carboxamide (V) can be obtained as follows. Esterification of L-pyroglutamic acid (XXIX) with ethanolic H2SO4 followed by protection with Boc2O gives 1-Boc-5-oxoproline ethyl ester (XXXI). After reduction of (XXXI) with LiBHEt3, the obtained hemiaminal (XXXII) is dehydrated to the dehydroproline derivative (XXXIII) employing trifluoroacetic anhydride, DMAP and DIEA. Subsequent hydrolysis of ethyl ester (XXXIII) by means of LiOH leads to the carboxylic acid (XXXIV), which is converted to the corresponding carboxamide (XXXV) via activation with methanesulfonyl chloride, followed by reaction with ammonia. Simmons-Smith cyclopropanation of (XXXV) using diiodomethane and diethylzinc gives the bicyclic derivative (XXXVI), which is then deprotected under acidic conditions to furnish (1S,3S,5S)-2-azabicyclo[3.1.0]hexane-3-carboxamide (V) (2, 3). Scheme 4.

2 Vu, T.C., Hamann, L.G., Fox, R. et al. (Bristol-Myers Squibb Co.). Methods and compounds producing dipeptidyl peptidase IV inhibitors and intermediates thereof. JP 200651621, US 2005090539, WO 2004052850.
3 Politino, M., Cadin, M.M., Skonezny, P.M., Chen, J.G. (Bristol-Myers Squibb Co.). EP 1737970, JP 2007532137, WO 2005106011.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(V) 65682 (1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide 361440-68-8 C6H10N2O 详情 详情
(XXIX) 32406 (2S)-5-oxo-2-pyrrolidinecarboxylic acid 98-79-3 C5H7NO3 详情 详情
(XXX) 65704 Ethyl L-pyroglutamate; Ethyl 5-oxo-L-prolinate; Ethyl (S)-(+)-2-pyrrolidone-5-carboxylate; 5-Oxo-proline ethyl ester; L(+)-Pyroglutamic acid ethyl ester 7149-65-7 C7H11NO3 详情 详情
(XXXI) 43914 1-(tert-butyl) 2-ethyl (2S)-5-oxo-1,2-pyrrolidinedicarboxylate 144978-35-8 C12H19NO5 详情 详情
(XXXII) 65705     C12H21NO5 详情 详情
(XXXIII) 65706 (S)-1-Boc-2,3-dihydro-2-pyrrolecarboxylic acid ethyl ester; (S)-1-tert-Butyl 2-ethyl 2,3-dihydro-1H-pyrrole-1,2-dicarboxylate; Ethyl N-Boc-L-proline-4-ene 178172-26-4 C12H19NO4 详情 详情
(XXXIV) 65707 (S)-1-(tert-Butoxycarbonyl)-2,5-dihydro-1H-pyrrole-2-carboxylic acid; Boc-3,4-Dehydro-Pro-OH 51154-06-4 C10H15NO4 详情 详情
(XXXV) 65708 (2S)-2-(Aminocarbonyl)-2,3-dihydro-1H-pyrrole-1-carboxylic acid 1,1-dimethylethyl ester 709031-38-9 C10H16N2O3 详情 详情
(XXXVI) 65709 (1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester 361440-67-7 C11H18N2O3 详情 详情

合成路线5

 

1 Hnanson RL, Goldberg SL, Brzozowski DB, et al. 2007. Preparation of an amino acid intermediate for the dipeptidyl peptidase IV inhibitor, saxagliptin, using a modified phenylalanine dehydrogenase. Adv Synth Catal, 349: 1369~1378.
2 Sharma PN, Galvin GM, Boettger SD, et al.2006. Ammonolysis process for the preparation of intermediates for DPP IV inhibitors. US 2006/0035954 A1.
3 Vu TC, Brzozowski DB, Fox R, et al.2004. Methods and compounds producing dipeptidyl peptidase IV inhibitors and intermediates thereof. WO 2004/052850 A2.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 65680 N-Boc-(S)-(3-hydroxyadamantyl)glycine   C17H28NO5 详情 详情
(II) 67425 (1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide methanesulfonate   C6H10N2O.CH4O3S 详情 详情
(III) 65683     C23H36N3O5 详情 详情
(IV) 67426 3-((1R)-1-((tert-butoxycarbonyl)amino)-2-((1R,5R)-3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)adamantan-1-yl 2,2,2-trifluoroacetate   C25H32F3N3O5 详情 详情
(V) 65686     C22H34N3O5 详情 详情

合成路线6

 

中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VIII) 65680 N-Boc-(S)-(3-hydroxyadamantyl)glycine   C17H28NO5 详情 详情
(I) 62440 methyl 2,2,2-trichloroacetate 598-99-2 C3H3Cl3O2 详情 详情
(II) 65698 1-Bromoadamantane; 1-Bromotricyclo[3.3.1.1(3,7)]decane; 1-Adamantyl bromide 768-90-1 C10H15Br 详情 详情
(III) 67428 methyl 2-(adamantan-1-yl)-2,2-dichloroacetate   C13H18Cl2O2 详情 详情
(IV) 67429 methyl 2,2-dichloro-2-(3-hydroxyadamantan-1-yl)acetate   C13H18Cl2O3 详情 详情
(V) 67430 2,2-dichloro-2-(3-hydroxyadamantan-1-yl)acetic acid   C12H16Cl2O3 详情 详情
(VI) 65703 2-(3-Hydroxy-1-adamantyl)-2-oxoacetic acid; 3-Hydroxy-alpha-oxotricyclo[3.3.1.1(3,7)]decane-1-acetic acid; 709031-28-7 C12H16O4 详情 详情
(VII) 65681 (S)-(3-hydroxyadamantyl)glycine   C12H19NO3 详情 详情
(IX) 67427 ((2,2-dichloro-1-methoxyvinyl)oxy)trimethylsilane   C6H12Cl2O2Si 详情 详情

合成路线7

 

中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VI) 65708 (2S)-2-(Aminocarbonyl)-2,3-dihydro-1H-pyrrole-1-carboxylic acid 1,1-dimethylethyl ester 709031-38-9 C10H16N2O3 详情 详情
(VIII) 67425 (1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide methanesulfonate   C6H10N2O.CH4O3S 详情 详情
(I) 32406 (2S)-5-oxo-2-pyrrolidinecarboxylic acid 98-79-3 C5H7NO3 详情 详情
(II) 65704 Ethyl L-pyroglutamate; Ethyl 5-oxo-L-prolinate; Ethyl (S)-(+)-2-pyrrolidone-5-carboxylate; 5-Oxo-proline ethyl ester; L(+)-Pyroglutamic acid ethyl ester 7149-65-7 C7H11NO3 详情 详情
(III) 43914 1-(tert-butyl) 2-ethyl (2S)-5-oxo-1,2-pyrrolidinedicarboxylate 144978-35-8 C12H19NO5 详情 详情
(IV) 65706 (S)-1-Boc-2,3-dihydro-2-pyrrolecarboxylic acid ethyl ester; (S)-1-tert-Butyl 2-ethyl 2,3-dihydro-1H-pyrrole-1,2-dicarboxylate; Ethyl N-Boc-L-proline-4-ene 178172-26-4 C12H19NO4 详情 详情
(V) 65707 (S)-1-(tert-Butoxycarbonyl)-2,5-dihydro-1H-pyrrole-2-carboxylic acid; Boc-3,4-Dehydro-Pro-OH 51154-06-4 C10H15NO4 详情 详情
Extended Information